Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC
Clinical trial NCT06811844 · RECRUITING
Trial details
- NCT number
- NCT06811844
- Sponsor
- The First Affiliated Hospital of Xiamen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-25
- Primary completion
- 2027-12-31
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.